Evaluation serum levels of YKL-40, Periostin, and some inflammatory cytokines together with IL-37, a new anti-inflammatory cytokine, in patients with stable and exacerbated asthma

Yildiz, Hanifi; Alp, Hamit; Sünnetçioğlu, A; Ekin, Selami; Mermit, Buket

doi:10.1016/j.hrtlng.2020.04.017

Evaluation serum levels of YKL-40, Periostin, and some inflammatory cytokines together with IL-37, a new anti-inflammatory cytokine, in patients with stable and exacerbated asthma

Atıf İçin Kopyala

Yildiz H., Alp H. H., Sünnetçioğlu A., Ekin S., Mermit Ç.

HEART & LUNG, cilt.50, sa.1, ss.177-183, 2021 (SCI-Expanded)

Yayın Türü: Makale / Tam Makale
Cilt numarası: 50 Sayı: 1
Basım Tarihi: 2021
Doi Numarası: 10.1016/j.hrtlng.2020.04.017
Dergi Adı: HEART & LUNG
Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus, CINAHL, EMBASE, MEDLINE
Sayfa Sayıları: ss.177-183
Anahtar Kelimeler: Asthma, exacerbation, periostin, YKL-40, IL-37, cytokines, ALLERGIC AIRWAY INFLAMMATION, NECROSIS-FACTOR-ALPHA, TNF-ALPHA, LUNG, IL-18R-ALPHA, BIOMARKERS, DIAGNOSIS, PHENOTYPE, SEVERITY, MARKERS
Van Yüzüncü Yıl Üniversitesi Adresli: Evet

Özet

Introduction: As asthma has a wide range of inflammatory pathways, the researchers were focused on the markers that may be associated with exacerbation and stability in asthma.